Designates November of each year as "Diabetes and Cardiovascular Disease Awareness Month."
Impact
The resolution highlights the relationship between diabetes and cardiovascular diseases, underscoring the heightened risks faced by individuals with type 2 diabetes. Studies indicate that a significant percentage of adults with type 2 diabetes are unaware of their increased cardiovascular risks. Furthermore, substantial healthcare costs are linked to diabetes treatment, with New Jersey reporting Medicare expenses of nearly $1.5 billion for this condition. By establishing an awareness month, the state aims to foster improved public understanding and potentially reduce healthcare costs associated with diabetes-related complications.
Summary
AJR118 is a Joint Resolution introduced in New Jersey that designates November of each year as 'Diabetes and Cardiovascular Disease Awareness Month.' The intention behind this resolution is to raise public awareness regarding the connections between diabetes, particularly type 2 diabetes, and cardiovascular diseases. Given that diabetes affects over 29 million Americans and ranks as the seventh leading cause of death in the U.S., promoting awareness is considered vital. The resolution calls for educational activities and programs to inform both the public and policymakers about the significance of these health issues.
Contention
While AJR118 is largely a non-controversial resolution focused on public health awareness, it does bring attention to the disparities in diabetes prevalence among African American and Hispanic populations in New Jersey. The high rates of diabetes and related health complications in these communities indicate a need for targeted public health initiatives. There is a broader recognition that effective awareness and education strategies can significantly impact public health outcomes, particularly in at-risk groups, although potential debate may arise regarding the allocation of resources for such programs.